Search | IOVS | ARVO Journals

Showing 1 – 20 of 23

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2022

National physician survey on clinical practice patterns for the treatment of noninfectious uveitis

Megan E Cavet; Shelley Hancock; Thomas A Ciulla

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3200 – A0426.

ARVO Annual Meeting Abstract June 2021

In Vitro Potency of Tobramycin Against Common Bacterial Pathogens Implicated in Blepharitis

James E Deom; Megan E Cavet; Christine M Sanfilippo; Heleen H DeCory

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):414.

ARVO Annual Meeting Abstract June 2021

Occurrence of steroid-associated adverse events with loteprednol etabonate formulations

Megan E Cavet; Heleen H DeCory

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):720.

ARVO Annual Meeting Abstract June 2021

Dose uniformity of loteprednol etabonate (submicron) ophthalmic gel 0.38% compared with prednisolone acetate ophthalmic suspension 1.0%

Zora T Marlowe; Megan E Cavet; Martin J Coffey

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):719.

ARVO Annual Meeting Abstract July 2019

Proportion of subjects achieving zero-trace anterior chamber inflammation with loteprednol etabonate (submicron) gel 0.38% following cataract surgery: Integrated analysis of 3 pivotal trials

Joseph Martel; Raymond Fong; Megan E Cavet; Jason Vittitow

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):251.

ARVO Annual Meeting Abstract July 2018

Antibiotic Resistance in Ocular Pathogens – Preliminary Results from the 2017 ARMOR Surveillance Program

Christine M Sanfilippo; Megan E Cavet; Heleen DeCory; Penny A Asbell

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2659.

ARVO Annual Meeting Abstract July 2018

Antibiotic Resistance Trends Among Staphylococci in the ARMOR Study: 2009-2017

Penny A Asbell; Christine M Sanfilippo; Megan E Cavet; Heleen DeCory

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3676.

ARVO Annual Meeting Abstract June 2017

Assessment of ophthalmic steroid class adverse event reports for loteprednol etabonate

Megan E Cavet; Christine M Sanfilippo; Heleen H DeCory

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1082.

ARVO Annual Meeting Abstract September 2016

Impact of the topical ophthalmic corticosteroid loteprednol etabonate on intraocular pressure

Megan E Cavet; Heleen H DeCory; John D Sheppard

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5405.

Glaucoma June 2015

Regulation of Endothelin-1–Induced Trabecular Meshwork Cell Contractility by Latanoprostene Bunod

PDF

Megan E. Cavet; Thomas R. Vollmer; Karen L. Harrington; Karl VanDerMeid; Mary E. Richardson
TAGS: endothelin-1, latanoprost, trabecular meshwork, cyclic gmp, regulation, donors
Invest. Ophthalmol. Vis. Sci.. 2015; 56(6):4108-4116. https://doi.org/10.1167/iovs.14-16015

ARVO Annual Meeting Abstract June 2015

Ocular pharmacokinetics of submicron loteprednol etabonate ophthalmic gel, 0.38% following topical administration in rabbits

Megan E Cavet; Shellise Glogowski; Christopher DiSalvo; Mary Elise Richardson

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1524.

Review August 2014

Nitric Oxide (NO): An Emerging Target for the Treatment of Glaucoma

PDF

Megan E. Cavet; Jason L. Vittitow; Francesco Impagnatiello; Ennio Ongini; Elena Bastia
TAGS: donors, glaucoma, intraocular pressure, nitric oxide
Invest. Ophthalmol. Vis. Sci.. 2014; 55(8):5005-5015. https://doi.org/10.1167/iovs.14-14515

ARVO Annual Meeting Abstract April 2014

NO-induced Regulation of Primary Human Trabecular Meshwork Cell Contractility by Latanoprostene Bunod

Megan E Cavet; Thomas R Vollmer; Karen Harrington; Karl VanDerMeid; Mary Richardson

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):546.

ARVO Annual Meeting Abstract April 2014

Anti-inflammatory effects of the glucocorticoid loteprednol etabonate in human ocular and inflammatory cells

Thomas R Vollmer; Megan E Cavet; Karen L Harrington; Stepan M Volhejn; Mary Richardson

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):6297.

ARVO Annual Meeting Abstract April 2011

Effect Of Polyhexamethylene Biguanide On Human Corneal Epithelial Barrier Function

Jin-Zhong Zhang; Karl R. VanDerMeid; Karen L. Harrington; Megan E. Cavet; Keith W. Ward

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):291.

ARVO Annual Meeting Abstract April 2011

Anti-Inflammatory And Anti-Oxidant Effects Of The Green Tea Polyphenol Epigallocatechin Gallate In Human Corneal Epithelial Cells

Karen L. Harrington; Megan E. Cavet; Thomas R. Vollmer; Stepan M. Volhejn; Jessica E. Ackerman; Keith W. Ward; Jin-Zhong Zhang

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):311.

ARVO Annual Meeting Abstract April 2011

Anti-Allergic Effects of Mapracorat, a Novel Selective Glucocorticoid Receptor Agonist, in Human Conjunctival Fibroblasts and Epithelial Cells

Megan E. Cavet; Stepan M. Volhejn; Karen L. Harrington; Thomas Vollmer; Keith W. Ward; Jin-Zhong Zhang

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):6422.

ARVO Annual Meeting Abstract April 2010

Ocular Biocompatibility of Boric Acid and a Borate-Buffered Multipurpose Solution

D. M. Lehmann; M. E. Cavet; D. J. O'Mara; K. L. Harrington; M. E. Richardson

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):3408.

ARVO Annual Meeting Abstract April 2010

BOL-303242-X, a Novel Selective Glucocorticoid Receptor Agonist, Inhibits Hyperosmolarity-Induced Cytokine Release in Human Corneal Epithelial Cells

J.-Z. Zhang; M. E. Cavet; K. L. Harrington; K. R. VanDerMeid; F. J. Lopez; K. W. Ward

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):4859.

Physiology and Pharmacology January 2010

Reduced Myocilin Expression in Cultured Monkey Trabecular Meshwork Cells Induced by a Selective Glucocorticoid Receptor Agonist: Comparison with Steroids

PDF

Bruce A. Pfeffer; Charu A. DeWitt; Mercedes Salvador-Silva; Megan E. Cavet; Francisco J. López; Keith W. Ward
TAGS: agonists, cercopithecidae, glucocorticoid receptors, myoc gene, proteins, steroids, trabecular meshwork, rna, messenger
Invest. Ophthalmol. Vis. Sci.. 2010; 51(1):437-446. https://doi.org/10.1167/iovs.09-4202

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

National physician survey on clinical practice patterns for the treatment of noninfectious uveitis

In Vitro Potency of Tobramycin Against Common Bacterial Pathogens Implicated in Blepharitis

Occurrence of steroid-associated adverse events with loteprednol etabonate formulations

Dose uniformity of loteprednol etabonate (submicron) ophthalmic gel 0.38% compared with prednisolone acetate ophthalmic suspension 1.0%

Proportion of subjects achieving zero-trace anterior chamber inflammation with loteprednol etabonate (submicron) gel 0.38% following cataract surgery: Integrated analysis of 3 pivotal trials

Antibiotic Resistance in Ocular Pathogens – Preliminary Results from the 2017 ARMOR Surveillance Program

Antibiotic Resistance Trends Among Staphylococci in the ARMOR Study: 2009-2017

Assessment of ophthalmic steroid class adverse event reports for loteprednol etabonate

Impact of the topical ophthalmic corticosteroid loteprednol etabonate on intraocular pressure

Regulation of Endothelin-1–Induced Trabecular Meshwork Cell Contractility by Latanoprostene Bunod

Ocular pharmacokinetics of submicron loteprednol etabonate ophthalmic gel, 0.38% following topical administration in rabbits

Nitric Oxide (NO): An Emerging Target for the Treatment of Glaucoma

NO-induced Regulation of Primary Human Trabecular Meshwork Cell Contractility by Latanoprostene Bunod

Anti-inflammatory effects of the glucocorticoid loteprednol etabonate in human ocular and inflammatory cells

Effect Of Polyhexamethylene Biguanide On Human Corneal Epithelial Barrier Function

Anti-Inflammatory And Anti-Oxidant Effects Of The Green Tea Polyphenol Epigallocatechin Gallate In Human Corneal Epithelial Cells

Anti-Allergic Effects of Mapracorat, a Novel Selective Glucocorticoid Receptor Agonist, in Human Conjunctival Fibroblasts and Epithelial Cells

Ocular Biocompatibility of Boric Acid and a Borate-Buffered Multipurpose Solution

BOL-303242-X, a Novel Selective Glucocorticoid Receptor Agonist, Inhibits Hyperosmolarity-Induced Cytokine Release in Human Corneal Epithelial Cells

Reduced Myocilin Expression in Cultured Monkey Trabecular Meshwork Cells Induced by a Selective Glucocorticoid Receptor Agonist: Comparison with Steroids

To View More...

You must be signed into an individual account to use this feature.